Roanoke Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-34,966
| Closed | -$1.57M | – | 90 |
|
|
2024
Q4 | $1.57M | Sell |
34,966
-1,378
| -4% | -$77.3K | 0.51% | 48 |
|
|
2024
Q3 | $2.29M | Sell |
36,344
-1,337
| -4% | -$78K | 0.72% | 43 |
|
|
2024
Q2 | $2.23M | Sell |
37,681
-782
| -2% | -$48.9K | 0.73% | 42 |
|
|
2024
Q1 | $3.07M | Sell |
38,463
-291
| -0.8% | -$22.2K | 1.01% | 39 |
|
|
2023
Q4 | $3.06M | Sell |
38,754
-388
| -1% | -$27.6K | 1.13% | 35 |
|
|
2023
Q3 | $2.73M | Sell |
39,142
-1,215
| -3% | -$86.1K | 1.12% | 38 |
|
|
2023
Q2 | $2.79M | Buy |
40,357
+1,820
| +5% | +$129K | 1.1% | 37 |
|
|
2023
Q1 | $2.86M | Sell |
38,537
-1
| -0% | -$84 | 1.22% | 32 |
|
|
2022
Q4 | $3.59M | Sell |
38,538
-2,586
| -6% | -$250K | 1.63% | 19 |
|
|
2022
Q3 | $3.92M | Sell |
41,124
-292
| -0.7% | -$28.9K | 1.87% | 16 |
|
|
2022
Q2 | $3.84M | Buy |
41,416
+1,279
| +3% | +$125K | 1.72% | 17 |
|
|
2022
Q1 | $4.06M | Sell |
40,137
-3,687
| -8% | -$387K | 1.51% | 23 |
|
|
2021
Q4 | $4.52M | Sell |
43,824
-232
| -0.5% | -$21.4K | 1.5% | 20 |
|
|
2021
Q3 | $3.74M | Buy |
44,056
+539
| +1% | +$45.1K | 1.33% | 27 |
|
|
2021
Q2 | $3.63M | Buy |
43,517
+9,140
| +27% | +$748K | 1.26% | 27 |
|
|
2021
Q1 | $2.59M | Buy |
34,377
+3,305
| +11% | +$241K | 1.12% | 31 |
|
|
2020
Q4 | $2.12M | Sell |
31,072
-1,835
| -6% | -$119K | 1% | 36 |
|
|
2020
Q3 | $1.92M | Buy |
32,907
+10
| +0% | +$622 | 1.05% | 34 |
|
|
2020
Q2 | $2.14M | Sell |
32,897
-4,108
| -11% | -$259K | 1.24% | 29 |
|
|
2020
Q1 | $2.2M | Sell |
37,005
-260
| -0.7% | -$17.4K | 1.48% | 26 |
|
|
2019
Q4 | $2.77M | Sell |
37,265
-9,410
| -20% | -$661K | 1.38% | 27 |
|
|
2019
Q3 | $2.94M | Sell |
46,675
-905
| -2% | -$53.6K | 1.38% | 25 |
|
|
2019
Q2 | $2.59M | Buy |
47,580
+30
| +0.1% | +$1.62K | 1.17% | 28 |
|
|
2019
Q1 | $2.56M | Buy |
47,550
+13,263
| +39% | +$819K | 1.19% | 28 |
|
|
2018
Q4 | $2.25M | Buy |
34,287
+1,125
| +3% | +$84K | 1.19% | 33 |
|
|
2018
Q3 | $2.61M | Hold |
33,162
| – | – | 1.17% | 34 |
|
|
2018
Q2 | $2.13M | Sell |
33,162
-3,555
| -10% | -$234K | 1.03% | 41 |
|
|
2018
Q1 | $2.28M | Buy |
36,717
+11,285
| +44% | +$810K | 1.1% | 38 |
|
|
2017
Q4 | $1.84M | Sell |
25,432
-3,070
| -11% | -$223K | 0.88% | 41 |
|
|
2017
Q3 | $2.32M | Sell |
28,502
-3,835
| -12% | -$303K | 1.09% | 38 |
|
|
2017
Q2 | $2.6M | Sell |
32,337
-2,340
| -7% | -$185K | 1.23% | 33 |
|
|
2017
Q1 | $2.72M | Buy |
34,677
+2,955
| +9% | +$236K | 1.29% | 32 |
|
|
2016
Q4 | $2.5M | Sell |
31,722
-250
| -0.8% | -$20.2K | 1.14% | 41 |
|
|
2016
Q3 | $2.85M | Sell |
31,972
-1,090
| -3% | -$103K | 1.28% | 33 |
|
|
2016
Q2 | $3.17M | Sell |
33,062
-85
| -0.3% | -$8.47K | 1.47% | 29 |
|
|
2016
Q1 | $3.44M | Sell |
33,147
-900
| -3% | -$87.5K | 1.59% | 28 |
|
|
2015
Q4 | $3.33M | Sell |
34,047
-4,500
| -12% | -$441K | 1.42% | 32 |
|
|
2015
Q3 | $3.72M | Buy |
38,547
+7,000
| +22% | +$736K | 1.37% | 31 |
|
|
2015
Q2 | $3.31M | Buy |
31,547
+580
| +2% | +$59.3K | 1.06% | 37 |
|
|
2015
Q1 | $3.2M | Buy |
30,967
+24,020
| +346% | +$2.43M | 1.05% | 38 |
|
|
2014
Q4 | $669K | Buy |
6,947
+5
| +0.1% | +$441 | 0.23% | 74 |
|
|
2014
Q3 | $553K | Buy |
6,942
+200
| +3% | +$15.8K | 0.23% | 69 |
|
|
2014
Q2 | $508K | Hold |
6,742
| – | – | 0.19% | 73 |
|
|
2014
Q1 | $505K | Sell |
6,742
-80
| -1% | -$5.65K | 0.22% | 70 |
|
|
2013
Q4 | $488K | Hold |
6,822
| – | – | 0.22% | 71 |
|
|
2013
Q3 | $439K | Buy |
+6,822
| New | +$407K | 0.21% | 72 |
|
Other funds holding CVS
Roanoke Asset Management's CVS Position: Q1 2025 in Review
Roanoke Asset Management sold out of CVS Health (CVS) in Q1 2025, closing a stake of 34,966 shares — an estimated $1.57M sold.
Roanoke Asset Management first reported a position in CVS in Q3 2013 and held it in 46 quarters. The position peaked at $4.52M in Q4 2021. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.
- Roanoke Asset Management reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
- Roanoke Asset Management sold 34,966 CVS Health shares in Q1 2025, an estimated $1.57M.
- Roanoke Asset Management first reported a position in CVS Health in Q3 2013 and held it in 46 quarters.
- Roanoke Asset Management's CVS Health position peaked at $4.52M in Q4 2021.
- 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.
Based on Roanoke Asset Management's 13F filing for Q1 2025, filed 13 May 2025.